Article
Sanofi announces positive data for frexalimab product to treat multiple sclerosis
Rating:
0.0
Views:
66
Likes:
1
Library:
1
French healthcare company Sanofi announced on Wednesday positive data for its frexalimab product aimed at treating multiple sclerosis, and that the firm plans to initiate pivotal trials in multiple sclerosis in early 2024.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value